SNX insider sale: 870 shares disposed, holdings remain sizable

Rhea-AI Filing Summary

TD SYNNEX director and officer Dennis Polk reported a non-derivative sale of 870 shares of common stock on 10/07/2025 at a price of $158.65 per share. After the sale he directly beneficially owns 31,117 shares and indirectly owns 81,660 shares through a trust, showing continued significant aggregate holdings while executing a small disposition. The form was signed by an attorney-in-fact on 10/09/2025.

Positive

• Transparency maintained through timely Form 4 filing signed on 10/09/2025
• Significant aggregate ownership remains: 31,117 direct + 81,660 indirect shares

Negative

• Insider sale of 870 shares at $158.65 reduced direct holdings

Insights

Corporate Governance Analyst

Small insider sale, but substantial aggregate holdings remain.

The reported transaction is a routine non-derivative sale of 870 shares at $158.65 on 10/07/2025

Such sales can be for personal-liquidity reasons; the combination of 31,117 direct and 81,660 indirect shares indicates continued alignment with shareholders. Watch for further Form 4 filings within the next quarter for any trend in net disposals.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

POLK DENNIS

(Last) (First) (Middle)

44201 NOBEL DRIVE

(Street)

FREMONT CA 94538

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TD SYNNEX CORP [ SNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Hyve Solutions Executive

3. Date of Earliest Transaction (Month/Day/Year)
10/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/07/2025		F		870	D	$158.65	31,117	D
Common Stock								81,660	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Cheryl Grant, attorney-in-fact	10/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Dennis Polk report on the Form 4 for SNX?

Dennis Polk reported selling 870 shares of TD SYNNEX common stock on 10/07/2025 at $158.65 per share.

How many TD SYNNEX (SNX) shares does Dennis Polk own after the sale?

31,117 shares directly and 81,660 shares indirectly via a trust following the reported transaction.

When was the Form 4 filed or signed?

The Form 4 shows the transaction date as 10/07/2025 and it was signed by an attorney-in-fact on 10/09/2025.

Was the reported transaction a derivative or non-derivative trade?

Non-derivative: the filing lists a sale of common stock (no options or other derivatives reported).

Does the filing indicate any trading plan or 10b5-1 election?

The filing does not state that the transaction was made pursuant to a trading plan or 10b5-1; no such plan is disclosed in the form content provided.